Your goals.
Real data.
A research program.
Yours.
This page describes a proposed research-access concept. Biopeptídeo is a marketing platform, not a clinical provider; no active study or prescribing service is confirmed.

Research, done with you — not just on you.
No approved Biopeptídeo study or clinical partnership has been verified. Any future human research requires applicable ethics and regulatory review before enrolment. Only licensed professionals may assess suitability or prescribe.
That data is what makes the research real — and it’s what keeps the program safe, measured and honest.
Answer four questions
Tell us about yourself, your goals and your health history in a short questionnaire.
A partner agency reviews
Our partner research agencies assess your candidacy and, where appropriate, prescribe.
Track together
If accepted, your progress data is tracked with the agency throughout the program.
Twenty-four weeks, four checkpoints.
The program keeps a fixed shape so nothing drifts: a baseline before your first dose, then three set reviews with the partner agency.
- Week 0
Baseline
Intake, bloodwork and measurements, taken before your first dose.
- Week 4
First check
Tolerability and adherence reviewed; the dose is adjusted where it needs to be.
- Week 12
Review
Bloodwork repeated against baseline. The agency decides to continue, adjust or stop.
- Week 24
Close-out
A full write-up of your data, read together with you and the agency.
Are you a candidate?
The program isn’t for everyone. You’re likely a good candidate if all of the following are true:
- You are 18 or older and live in South or Central Brazil.
- You have a clear research or health goal you want to work toward.
- You are willing to share progress data with a partner research agency.
- You are not pregnant, breastfeeding, or advised against peptide use by a physician.
See if you qualify.
Record interest only. No clinical review, reply, prescribing or study enrolment is guaranteed. Do not submit sensitive health details while privacy arrangements remain incomplete.
Start the questionnaireYou’ll be taken to a separate page to answer them.